Showing results (191-200 of 374) with videos related to
Sort By:
Pageof 38
Nature Reviews. Clinical Oncology|April 14, 2011
The biology of brain metastases-translation to new therapiesApril F Eichler, Euiheon Chung, David P Kodack, et al.Scientific Reports|April 15, 2020
Post-operative radiation therapy to the surgical cavity with standard fractionation in patients with brain metastasesJames D Byrne, Thomas Botticello, Andrzej Niemierko, et al.International Journal of Radiation Oncology, Biology, Physics|June 15, 1994
A phase I study of etanidazole and radiotherapy in malignant gliomaN E Riese, J S Loeffler, P Wen, et al.Nature Reviews. Clinical Oncology|June 7, 2018
Safety of combining radiotherapy with immune-checkpoint inhibitionWilliam L Hwang, Luke R G Pike, Trevor J Royce, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2004
The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomasArnab Chakravarti, Gary Zhai, Yoshiyuki Suzuki, et al.AJNR. American Journal of Neuroradiology|November 1, 1991
Radiation necrosis vs high-grade recurrent glioma: differentiation by using dual-isotope SPECT with 201TI and 99mTc-HMPAOR B Schwartz, P A Carvalho, E Alexander, et al.International Journal of Radiation Oncology, Biology, Physics|May 31, 2011
Outcomes after whole brain reirradiation in patients with brain metastasesChristina H Son, Rachel Jimenez, Andrzej Niemierko, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|April 28, 2015
Repeat radiosurgery for cerebral arteriovenous malformationsAhmed J Awad, Brian P Walcott, Christopher J Stapleton, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphomaPaul L Nguyen, Arnab Chakravarti, Dianne M Finkelstein, et al.Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|August 26, 2010
Erlotinib for progressive vestibular schwannoma in neurofibromatosis 2 patientsScott R Plotkin, Chris Halpin, Michael J McKenna, et al.Pageof 38